DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Survey of Optical Values of the Breast Using Radiation-Free Pressure-Free Optical Scanning

Information source: Spectros Corporation
ClinicalTrials.gov processed this data on August 20, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Breast Lesions; Breast Cyst; Early-Stage Breast Cancer; Benign Growth, Breast

Phase: N/A

Status: Recruiting

Sponsored by: Spectros Corporation

Official(s) and/or principal investigator(s):
David A Benaron, MD, Study Director, Affiliation: Spectros Corporation

Overall contact:
Lizzy van Thillo, AA, Phone: 650-851-4040, Ext: 549, Email: lizzy@spectros.com

Summary

The purposes of this study is to establish normal optical values of breast tissue in the general population. This will allow for establishing normals for breast composition, and is expected to be useful in the classification of breast lesions into groups such as cysts, benign growths, inflammatory lesions, and possibly early breast cancer.

Clinical Details

Official title: Early Screening of Breast Cancer Using Radiation-Free Pressure-Free Optical Scanning

Study design: Observational Model: Cohort, Time Perspective: Prospective

Primary outcome: Optical normals for the breast for a variety of conditions

Secondary outcome: Diagnostic compositional standards for (a) diagnosis of a condition such as cyst, benign growth, inflammation, and/or (b) referral for additional evaluation of a region of interest.

Eligibility

Minimum age: 21 Years. Maximum age: 50 Years. Gender(s): Female.

Criteria:

Inclusion Criteria:

- You must be female

- You must be 21 to 50 years old

- You must not have or have had breast cancer.

- You must not have or have had breast implants or breast surgery

- You must not have had a breast biopsy or injury, or a breast infection, in 90

days. Exclusion Criteria:

- Any one or more of the above conditions not met

- Lack of informed consent

Locations and Contacts

Lizzy van Thillo, AA, Phone: 650-851-4040, Ext: 549, Email: lizzy@spectros.com

Spectros Corporation, Portola Valley, California 94029, United States; Recruiting
Lizzy van Thillo, AA, Phone: 650-851-4040, Ext: 549, Email: lizzy@spectros.com
Carrie Bomarito, RN, Phone: 640-851-4040, Email: info@spectros.com
Additional Information

Starting date: April 2008
Last updated: January 30, 2011

Page last updated: August 20, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017